REFERENCES
- Bedi , G. , Cooper , Z.D. and Haney , M. 2012 . Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers . Addiction Biology ,
- Braitstein , P. , Kendall , T. , Chan , K. , Wood , E. , Montaner , J.S. , O'Shaughnessy , M.V. and Hogg , R.S. 2001 . Mary-Jane and her patients: Sociodemographic and clinical characteristics of HIVpositive individuals using medical marijuana and antiretroviral agents . AIDS , 15 ( 4 ) : 532 – 3 .
- Chong , M.S. , Wolff , K. , Wise , K. , Tanton , C. , Winstock , A. and Silber , E. 2006 . Cannabis use in patients with multiple sclerosis . Multiple Sclerosis , 12 ( 5 ) : 646 – 51 .
- Corless , I.B. , Lindgren , T. , Holzemer , W. , Robinson , L. , Moezzi , S. , Kirksey , K. , Coleman , C. , Tsai , Y.F. , Sanzero Eller , L. , Hamilton , M.J. , Sefcik , E.F. , Canaval , G.E. , Rivero Mendez , M. , Kemppainen , J.K. , Bunch , E.H. , Nicholas , P.K. , Nokes , K.M. , Dole , P. and Reynolds , N. 2009 . Marijuana effectiveness as an HIV self-care strategy . Clinical Nursing Research , 18 ( 2 ) : 172 – 93 .
- Courtney, W. 2012. Cannabis International, official website. Available at: http://www.cannabisinternational.org (http://www.cannabisinternational.org)
- Fischedick , J.T. , Hazekamp , A. , Erkelens , T. , Choi , Y.H. and Verpoorte , R. 2010 . Metabolic fingerprinting of Cannabis sativa L. cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes . Phytochemistry , 71 : 2058 – 73 .
- Freeman , R.M. , Adekanmi , O. , Waterfield , M.R. , Waterfield , A.E. , Wright , D. and Zajicek , J. 2006 . The effect of cannabis on urge incontinence in patients with multiple sclerosis: A multicentre, randomised placebo-controlled trial (CAMS-LUTS) . International Urogynecology Journal and Pelvic Floor Dysfunction , 17 ( 6 ) : 636 – 41 .
- Grotenhermen , F. and Russo , E. 2002 . Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential , New York : Haworth Press .
- Grotenhermen , F. 2003 . Pharmacokinetics and pharmacodynamics of cannabinoids . Clinical Pharmacokinetics , 42 ( 4 ) : 327 – 60 .
- GW Pharmaceuticals. 2012. Sativex® Mutual Recognition Procedure Closes with Recommendation for Approval in Ten European Countries. Available at: http://www.gwpharm.com/Sativex%20Mutual%20Recognition%20Procedure%20Closes%20with%20Recommendation%20for%20Approval%20in%20Ten%20European%20Countries.aspx (http://www.gwpharm.com/Sativex%20Mutual%20Recognition%20Procedure%20Closes%20with%20Recommendation%20for%20Approval%20in%20Ten%20European%20Countries.aspx)
- Haney , M. , Rabkin , J. , Gunderson , E. and Foltin , R.W. 2005 . Dronabinol and marijuana in HIV(+) marijuana smokers: Acute effects on caloric intake and mood . Psychopharmacology (Berlin) , 181 ( 1 ) : 170 – 78 .
- Haney , M. , Gunderson , E.W. , Rabkin , J. , Hart , C.L. , Vosburg , S.K. , Comer , S.D. and Foltin , R.W. 2007 . Dronabinol and marijuana in HIV-positive marijuana smokers: Caloric intake, mood, and sleep . Journal of Acquired Immune Deficiency Syndromes , 45 ( 5 ) : 545 – 54 .
- Hazekamp , A. , Ruhaak , R. , Zuurman , L. , van Gerven , J. and Verpoorte , R. 2006 . Evaluation of a vaporizing device (Volcano®) for the pulmonary delivery of tetrahydrocannabinol . Journal of Pharmaceutical Sciences , 95 ( 6 ) : 1308 – 17 .
- Hazekamp , A. , Bastola , K. , Rashidi , H. , Bender , J. and Verpoorte , R. 2007 . Cannabis tea revisited: A systematic evaluation of the cannabinoid composition of cannabis tea . Journal of Ethnopharmacology , 113 : 85 – 90 .
- Hazekamp , A. and Fischedick , J.T. 2012 . Cannabis - from cultivar to chemovar: Towards a better definition of cannabis potency . Drug Testing and Analysis , 4 : 660 – 7 .
- Hazekamp , A. and Heerdink , E.R. 2013 . The prevalence and incidence of medicinal cannabis on prescription in The Netherlands . European Journal of Clinical Pharmacology , in press
- Health Canada. 2011. Canada Federal Department of Health. Medical Marihuana Regulatory Reform 2011 Consultations Results. Available at: http://www.hc-sc.gc.ca/dhp-mps/consultation/marihuana/_2011/program/consult_reform-eng.php (http://www.hc-sc.gc.ca/dhp-mps/consultation/marihuana/_2011/program/consult_reform-eng.php)
- IACM (International Association for Cannabinoid Medicines). 2009. Laws and Politics of Germany, November 27, 2009. Available at: http://www.cannabis-med.org/index.php?tpl=page&id=44&lng=en (http://www.cannabis-med.org/index.php?tpl=page&id=44&lng=en)
- IACM (International Association for Cannabinoid Medicines). 2012. USA: Massachusetts becomes the 18th state to legalize the medical use of cannabis, November 18, 2012. Available at: http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=386#1 (http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=386#1)
- Killestein , J. , Hoogervorst , E.L. , Reif , M. , Kalkers , N.F. , Van Loenen , A.C. , Staats , P.G. , Gorter , R.W. , Uitdehaag , B.M. and Polman , C.H. 2002 . Safety, tolerability, and efficacy of orally administered cannabinoids in MS . Neurology , 58 ( 9 ) : 1404 – 7 .
- Lile , J.A. , Kelly , T.H. and Hays , L.R. 2011 . Separate and combined effects of the cannabinoid agonists nabilone and Δ9-THC in humans discriminating Δ9-THC . Drug and Alcohol Dependence , 116 ( 1–3 ) : 86 – 92 .
- McGilveray , I.J. 2005 . Pharmacokinetics of cannabinoids . Pain Research & Management , 10 ( Suppl A ) : 15A – 22A .
- Naef , M. , Russmann , S. , Petersen-Felix , S. and Brenneisen , R. 2004 . Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans . Journal of Pharmaceutical Sciences , 93 : 1176 – 84 .
- NCSM (Dutch Foundation for Legal Cannabis and its Constituents as Medicine). 2012. Reimbursement of medicinal cannabis by Dutch health insurance companies, March 28, 2012 (in Dutch). Available at: http://www.ncsm.nl/cfsystem/userData/pdf/1342695429__document__ncsm-vergoeding-medicinale-cannabis-2012.pdf (http://www.ncsm.nl/cfsystem/userData/pdf/1342695429__document__ncsm-vergoeding-medicinale-cannabis-2012.pdf)
- O'Connell , T.J. and Bou-Matar , C.B. 2007 . Long term marijuana users seeking medical cannabis in California (2001–2007): Demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants . Harm Reduction Journal , 4 : 16
- Ogborne , A.C. , Smart , R.G. and Adlaf , E.M. 2000 . Self-reported medical use of marijuana: A survey of the general population . Canadian Medical Association Journal , 162 ( 12 ) : 1685 – 6 .
- Page , S.A. , Verhoef , M.J. , Stebbins , R.A. , Metz , L.M. and Levy , J.C. 2003 . Cannabis use as described by people with multiple sclerosis . Canadian Journal of Neurological Sciences , 30 ( 3 ) : 201 – 5 .
- Pertwee , R.G. 1999 . Cannabis and cannabinoids: Pharmacology and rationale for clinical use . Forschende Komplementärmedizin , 6 ( Suppl 3 ) : 12 – 5 .
- Prentiss , D. , Power , R. , Balmas , G. , Tzuang , G. and Israelski , D.M. 2004 . Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting . Journal of Acquired Immune Deficiency Syndromes , 35 ( 1 ) : 38 – 45 .
- Russo , E.B. 2011 . Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects . British Journal of Pharmacology , 163 : 1344 – 64 .
- Simpson, R. 2012. February 1, 2013. Available at: http://phoenixtears.ca/ (http://phoenixtears.ca/)
- Strasser , F. , Luftnerl , D. , Possinger , K. , Ernst , G. , Ruhstaller , T. , Meissner , W. , Ko , Y.D. , Schnelle , M. , Reif , M. and Cerny , T. 2006 . Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group . Journal of Clinical Oncology , 24 ( 21 ) : 3394 – 400 .
- Tashkin , D.P. , Reiss , S. , Shapiro , B.J. , Calvarese , B. , Olsen , J.L. and Lodge , J.W. 1977 . Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects . American Review of Respiratory Disease , 115 ( 1 ) : 57 – 65 .
- Van der Kooy , F. , Pomahacova , B. and Verpoorte , R. 2009 . Cannabis smoke condensate II: Influence of tobacco on tetrahydrocannabinol levels . Inhalation Toxicology , 21 ( 2 ) : 87 – 90 .
- Ware , M.A. , Doyle , C.R. , Woods , R. , Lynch , M.E. and Clark , A.J. 2003 . Cannabis use for chronic non-cancer pain: Results of a prospective survey . Pain , 102 ( 1–2 ) : 211 – 6 .
- Ware , M.A. , Adams , H. and Guy , G.W. 2005 . The medicinal use of cannabis in the UK: Results of a nationwide survey . International Journal of Clinical Practice , 59 ( 3 ) : 291 – 95 .
- WHO (World Health Organization). 2006. Norms and Standards: Quality, Safety and Efficacy of Medicines. Available at: http://www.who.int/medicines/areas/quality_safety/4.2DronabinolCritReview.pdf (http://www.who.int/medicines/areas/quality_safety/4.2DronabinolCritReview.pdf)
- Zajicek , J. , Fox , P. , Sanders , H. , Wright , D. , Vickery , J. , Nunn , A. and Thompson , A. 2003 . Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial . Lancet , 362 ( 9395 ) : 1517 – 26 .
- Zajicek , J.P. , Sanders , H.P. , Wright , D.E. , Vickery , P.J. , Ingram , W.M. , Reilly , S.M. , Nunn , A.J. , Teare , L.J. , Fox , P.J. and Thompson , A.J. 2005 . Cannabinoids in multiple sclerosis (CAMS) study: Safety and efficacy data for 12 months follow-up . Journal of Neurology, Neurosurgery and Psychiatry , 76 ( 12 ) : 1664 – 9 .
- Žuškin , E. , Bouhuys , A. and Šari , M. 1981 . Lung function changes by ethanol inhalation . Clinical & Experimental Allergy , 11 ( 3 ) : 243 – 8 .